Deepverge FY revenues on track to meet guidance
Deepverge Plc
0.15p
17:30 19/12/23
Scientific research firm Deepverge gave investors an update on its revenue performance on Monday.
FTSE AIM All-Share
743.26
16:50 28/03/24
Pharmaceuticals & Biotechnology
21,366.25
17:14 28/03/24
Deepverge said it remained on track to deliver on its full-year guidance of £4.0m, while amalgamated revenues, which includes income from the recently acquired Modern Water, was anticipated to be well above the £4.0m mark.
Chief executive Gerard Brandon said: "The presentation will reiterate the guidance for 2020, provide an update on sales, marketing, supply chain management of products and services under development for a post-Covid world and I look forward to the opportunities that are ahead for the enlarged group."
As of 0900 GMT, Deepverge shares were up 4.29% at 27.95p.